Not applicableStudy completedNCT01933789What this trial is testingImproving Communication About Serious IllnessWho this might be right forCritical IllnessChronic DiseaseTerminal Care+9 more University of Washington 817
Not applicableStudy completedNCT01227213What this trial is testingThe Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell CarcinomaWho this might be right forHypertensionRenal FunctionInsulin Sensitivity+1 more Radboud University Medical Center 20
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Large-scale testing (Phase 3)WithdrawnNCT04006691What this trial is testingEfficacy and Safety of UGN-101 in Recurrent PatientsWho this might be right forCarcinomaTransitional Cell CarcinomaTransitional Cell Cancer of the Renal Pelvis and Ureter UroGen Pharma Ltd.
Not applicableActive Not RecruitingNCT06126159What this trial is testingMRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular MarkersWho this might be right forKidney Neoplasms Chang Gung Memorial Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT04150562What this trial is testingAvelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal CarcinomaWho this might be right forClear-Cell Renal Carcinoma National Cancer Institute (NCI) 2
Early research (Phase 1)Study completedNCT00483860What this trial is testingA Phase I Topotecan Study in Subjects With Cancer and Impaired Renal FunctionWho this might be right forSolid Tumours GlaxoSmithKline 59
Not applicableWithdrawnNCT01104389What this trial is testingFluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared ImagingWho this might be right forRenal Tumors Intuitive Surgical
Not applicableActive Not RecruitingNCT06916910What this trial is testingAnalysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum TumorsWho this might be right forPartial NephrectomyRenal Hilum TumorsUrinary Leakage First Affiliated Hospital of Fujian Medical University 200
Not applicableWithdrawnNCT04961320What this trial is testingOccupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 City of Hope Medical Center
Early research (Phase 1)Active Not RecruitingNCT04522323What this trial is testingEvaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaWho this might be right forAdvanced Renal Cell Carcinoma MedImmune LLC 67
Not applicableWithdrawnNCT02841020What this trial is testingThe Effect of Pre-treatment Biopsy for Non-neoplastic Renal Disease vs no Biopsy on Estimated Glomerular Filtration Rate in Patients With Small Renal Mass: a Single-center, Single-blinded, Randomized, Parallel Group Clinical TrialWho this might be right forKidney Neoplasms University of Virginia
Not applicableStudy completedNCT05579847What this trial is testingFeasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination ImmunotherapyWho this might be right forRenal Cell Carcinoma Stage IV H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableLooking for participantsNCT07555210What this trial is testingPilot Study of Bone Mineral Density Changes During Anti-PD-1 ImmunotherapyWho this might be right forBreast Cancer (Triple Negative Breast Cancer (TNBC))Renal Cell Carcinoma (Kidney Cancer)Melanoma (Skin Cancer)+5 more Jessica Mezzanotte Sharpe 25
Testing effectiveness (Phase 2)Ended earlyNCT00913913What this trial is testingBevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) PatientsWho this might be right forMetastatic Renal Cell Carcinoma Dartmouth-Hitchcock Medical Center 8
Not applicableActive Not RecruitingNCT06917560What this trial is testingSerological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter StudyWho this might be right forRenal CarcinomaSerologyAutoantibody First Affiliated Hospital of Fujian Medical University 400
Early research (Phase 1)Study completedNCT04846920What this trial is testingBelzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)Who this might be right forCarcinoma, Renal Cell Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Study completedNCT00540904What this trial is testingPrevention of Contrast Induced Nephropathy in Oncology Patients With Sodium BicarbonateWho this might be right forRadiographic Contrast Agent Nephropathy Barretos Cancer Hospital 27
Testing effectiveness (Phase 2)Study completedNCT02964078What this trial is testingInterleukin-2 and Pembrolizumab for Metastatic Kidney CancerWho this might be right forKidney Cancer H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00003585What this trial is testingBiological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerWho this might be right forKidney Cancer University of New Mexico 35